Pharmaceutical R&D industry report provides insights into what’s behind decline in global NME outputs and reveals implications of decreased projected expenditures.
News
Advertisement
Advertisement
Advertisement
The latest industry happenings from the past month, all in one place.
Sangamo executives, Melita Sun Jung and Amy Pooler, discuss the future of genomic medicines for autism spectrum disorder.
The latest industry happenings of the past month, all in one place.
W2O has announced findings from a research study on consumer attitudes toward data privacy, specifically personal health data.
Recent case study highlights the importance of applying statistical rigor throughout the development and validation processes of biomarkers.
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
